D
KalVista Pharmaceuticals, Inc. KALV
$13.31 $0.100.76% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

04/30/2025 01/31/2025 10/31/2024 07/31/2024 04/30/2024
Net Income -52.23M -48.51M -42.27M -40.44M -44.65M
Total Depreciation and Amortization 261.00K 229.00K 227.00K 224.00K 219.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 62.00K 10.01M 2.19M 2.31M 12.72M
Change in Net Operating Assets 11.54M 5.59M 213.00K -2.31M 16.61M
Cash from Operations -40.36M -32.68M -39.64M -40.22M -15.11M
Capital Expenditure -281.00K -24.00K -108.00K -21.00K -15.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -3.05M 8.54M 48.78M 37.18M -126.17M
Cash from Investing -3.33M 8.52M 48.67M 37.16M -126.19M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1.85M 56.54M 295.00K 3.00M 96.98M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 2.81M 95.23M -- -- 53.12M
Cash from Financing 4.66M 151.77M 295.00K 3.00M 150.10M
Foreign Exchange rate Adjustments 3.36M -1.25M 407.00K 117.00K -74.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -35.67M 126.36M 9.73M 59.00K 8.73M